Cesamet

Cesamet is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication. It was developed by the pharmaceutical company Eli Lilly and Company and was first approved for medical use in 1998. Cesamet is used to treat various conditions, including major depressive disorder, obsessive-compulsive disorder (OCD), panic disorder, and social anxiety disorder.

The active ingredient in Cesamet is escitalopram, which works by increasing the levels of serotonin in the brain. Serotonin is a neurotransmitter that plays a role in regulating mood, appetite, and sleep. By increasing serotonin levels, Cesamet helps to alleviate symptoms of depression and anxiety.

Cesamet is available in tablet form and is typically taken once or twice a day, depending on the dosage and the individual's response to treatment. The most common side effects of Cesamet include nausea, dizziness, drowsiness, and headache. Serious side effects, such as suicidal thoughts or behaviors, are rare but can occur.

Cesamet should be used under medical supervision. It is important to consult a healthcare provider before starting Cesamet, especially if the individual has a history of certain medical conditions or is taking other medications. Cesamet can interact with other drugs, so it is crucial to inform the healthcare provider about all medications being taken.

Cesamet is not a controlled substance in the United States, but it is subject to international controls. It is important to follow the guidelines provided by the prescribing healthcare provider and to store Cesamet properly to ensure its safety and effectiveness.